RNA interference mediated inhibition of Proprotein Convertase Subtilisin Kexin 9 (PCSK9) gene expression using short interfering nucleic acid (siNA)

Details for Australian Patent Application No. 2007275365 (hide)

Owner Sirna Therapeutics Inc.

Inventors Vargeese, Chandra; Vaish, Narendra K.; Guerciolini, Roberto; Jadhav, Vasant; McSwiggen, James

Agent Spruson & Ferguson

Pub. Number AU-A-2007275365

PCT Pub. Number WO2008/011431

Priority 60/861,369 28.11.06 US; 11/487,788 17.07.06 US

Filing date 17 July 2007

Wipo publication date 24 January 2008

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/011431 Priority application(s): WO2008/011431

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007275382-Remote sensing and actuation of fluid of inner ear

2007275360-Methods and medicaments for administration of ibuprofen